<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39005628</PMID><DateRevised><Year>2024</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-8021</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in genetics</Title><ISOAbbreviation>Front Genet</ISOAbbreviation></Journal><ArticleTitle>Mendelian randomization and Bayesian model averaging of autoimmune diseases and Long COVID.</ArticleTitle><Pagination><StartPage>1383162</StartPage><MedlinePgn>1383162</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1383162</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fgene.2024.1383162</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Following COVID-19, reports suggest Long COVID and autoimmune diseases (AIDs) in infected individuals. However, bidirectional causal effects between Long COVID and AIDs, which may help to prevent diseases, have not been fully investigated.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Summary-level data from genome-wide association studies (GWAS) of Long COVID (N = 52615) and AIDs including inflammatory bowel disease (IBD) (N = 377277), Crohn's disease (CD) (N = 361508), ulcerative colitis (UC) (N = 376564), etc. were employed. Bidirectional causal effects were gauged between AIDs and Long COVID by exploiting Mendelian randomization (MR) and Bayesian model averaging (BMA).</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The evidence of causal effects of IBD (OR = 1.06, 95% CI = 1.00-1.11, <i>p</i> = 3.13E-02), CD (OR = 1.10, 95% CI = 1.01-1.19, <i>p</i> = 2.21E-02) and UC (OR = 1.08, 95% CI = 1.03-1.13, <i>p</i> = 2.35E-03) on Long COVID was found. In MR-BMA, UC was estimated as the highest-ranked causal factor (MIP = 0.488, MACE = 0.035), followed by IBD and CD.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">This MR study found that IBD, CD and UC had causal effects on Long COVID, which suggests a necessity to screen high-risk populations.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Feng, Chen, Li, Ren, Chen, Li, Wu, Zhang, Yang, Li, Lu and Liu.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Feng</LastName><ForeName>Jieni</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>The Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Chen</LastName><ForeName>Jiankun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>The Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Second Affiliated Hospital (Guangdong Provincial Hospital of Chinese Medicine), Guangzhou University of Chinese Medicine, Guangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guangzhou Key Laboratory of Traditional Chinese Medicine for Prevention and Treatment of Emerging Infectious Diseases, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xiaoya</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>The Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ren</LastName><ForeName>Xiaolei</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>The Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Junxu</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>The First Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Zuming</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>The Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Second Affiliated Hospital (Guangdong Provincial Hospital of Chinese Medicine), Guangzhou University of Chinese Medicine, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Zhongde</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>The Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Second Affiliated Hospital (Guangdong Provincial Hospital of Chinese Medicine), Guangzhou University of Chinese Medicine, Guangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Rongyuan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>The Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Second Affiliated Hospital (Guangdong Provincial Hospital of Chinese Medicine), Guangzhou University of Chinese Medicine, Guangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guangzhou Key Laboratory of Traditional Chinese Medicine for Prevention and Treatment of Emerging Infectious Diseases, Guangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jiqiang</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>The Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Second Affiliated Hospital (Guangdong Provincial Hospital of Chinese Medicine), Guangzhou University of Chinese Medicine, Guangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guangzhou Key Laboratory of Traditional Chinese Medicine for Prevention and Treatment of Emerging Infectious Diseases, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Yue</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Second Affiliated Hospital (Guangdong Provincial Hospital of Chinese Medicine), Guangzhou University of Chinese Medicine, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yuntao</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Second Affiliated Hospital (Guangdong Provincial Hospital of Chinese Medicine), Guangzhou University of Chinese Medicine, Guangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guangzhou Key Laboratory of Traditional Chinese Medicine for Prevention and Treatment of Emerging Infectious Diseases, Guangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Genet</MedlineTA><NlmUniqueID>101560621</NlmUniqueID><ISSNLinking>1664-8021</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bayesian model averaging</Keyword><Keyword MajorTopicYN="N">Long Covid</Keyword><Keyword MajorTopicYN="N">Mendelian randomization</Keyword><Keyword MajorTopicYN="N">autoimmune diseases</Keyword><Keyword MajorTopicYN="N">causality</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>15</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>15</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>15</Day><Hour>5</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39005628</ArticleId><ArticleId IdType="pmc">PMC11240141</ArticleId><ArticleId IdType="doi">10.3389/fgene.2024.1383162</ArticleId><ArticleId IdType="pii">1383162</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Acosta-Ampudia Y., Monsalve D. M., Rojas M., Rodriguez Y., Zapata E., Ramirez-Santana C., et al. (2022). Persistent autoimmune activation and proinflammatory state in post-Coronavirus disease 2019 syndrome. J. Infect. Dis. 225 (12), 2155&#x2013;2162. 10.1093/infdis/jiac017</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac017</ArticleId><ArticleId IdType="pmc">PMC8903340</ArticleId><ArticleId IdType="pubmed">35079804</ArticleId></ArticleIdList></Reference><Reference><Citation>Ai Q., Yang B. (2023). Are inflammatory bowel diseases associated with an increased risk of COVID-19 susceptibility and severity? A two-sample Mendelian randomization study. Front. Genet. 14, 1095050. 10.3389/fgene.2023.1095050</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2023.1095050</ArticleId><ArticleId IdType="pmc">PMC10160392</ArticleId><ArticleId IdType="pubmed">37152982</ArticleId></ArticleIdList></Reference><Reference><Citation>Arachchillage D. J., Rajakaruna I., Pericleous C., Nicolson P. L. R., Makris M., Laffan M., et al. (2022). Autoimmune disease and COVID-19: a multicentre observational study in the United Kingdom. Rheumatol. Oxf. 61 (12), 4643&#x2013;4655. 10.1093/rheumatology/keac209</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keac209</ArticleId><ArticleId IdType="pmc">PMC8992350</ArticleId><ArticleId IdType="pubmed">35377457</ArticleId></ArticleIdList></Reference><Reference><Citation>Attauabi M., Dahlerup J. F., Poulsen A., Hansen M. R., Vester-Andersen M. K., Eraslan S., et al. (2022). Outcomes and long-term effects of COVID-19 in patients with inflammatory bowel diseases - a Danish Prospective population-based cohort study with individual-level data. J. Crohns Colitis 16 (5), 757&#x2013;767. 10.1093/ecco-jcc/jjab192</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ecco-jcc/jjab192</ArticleId><ArticleId IdType="pmc">PMC8689957</ArticleId><ArticleId IdType="pubmed">34755858</ArticleId></ArticleIdList></Reference><Reference><Citation>Avrameas S., Selmi C. (2013). Natural autoantibodies in the physiology and pathophysiology of the immune system. J. Autoimmun. 41, 46&#x2013;49. 10.1016/j.jaut.2013.01.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2013.01.006</ArticleId><ArticleId IdType="pubmed">23384670</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayd&#x131;n M. F., Ta&#x15f;demir H. (2021). Ulcerative colitis in a COVID-19 patient: a case report. Turk J. Gastroenterol. 32 (6), 543&#x2013;547. 10.5152/tjg.2021.20851</Citation><ArticleIdList><ArticleId IdType="doi">10.5152/tjg.2021.20851</ArticleId><ArticleId IdType="pmc">PMC8975413</ArticleId><ArticleId IdType="pubmed">34405821</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowden J., Davey Smith G., Burgess S. (2015). Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int. J. Epidemiol. 44 (2), 512&#x2013;525. 10.1093/ije/dyv080</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyv080</ArticleId><ArticleId IdType="pmc">PMC4469799</ArticleId><ArticleId IdType="pubmed">26050253</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowden J., Del Greco M. F., Minelli C., Davey Smith G., Sheehan N., Thompson J. (2017). A framework for the investigation of pleiotropy in two-sample summary data Mendelian randomization. Stat. Med. 36 (11), 1783&#x2013;1802. 10.1002/sim.7221</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.7221</ArticleId><ArticleId IdType="pmc">PMC5434863</ArticleId><ArticleId IdType="pubmed">28114746</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess S., Thompson S. G. (2017). Interpreting findings from Mendelian randomization using the MR-Egger method. Eur. J. Epidemiol. 32 (5), 377&#x2013;389. 10.1007/s10654-017-0255-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-017-0255-x</ArticleId><ArticleId IdType="pmc">PMC5506233</ArticleId><ArticleId IdType="pubmed">28527048</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess S., Thompson S. G., Collaboration C. C. G. (2011). Avoiding bias from weak instruments in Mendelian randomization studies. Int. J. Epidemiol. 40 (3), 755&#x2013;764. 10.1093/ije/dyr036</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyr036</ArticleId><ArticleId IdType="pubmed">21414999</ArticleId></ArticleIdList></Reference><Reference><Citation>Cayley W. E., Jr (2022). New-onset ulcerative colitis in patients with COVID-19. Am. Fam. Physician 106 (4), 362.</Citation><ArticleIdList><ArticleId IdType="pubmed">36260883</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F., Kulzhabayeva D., Rodrigues N. B., Di Vincenzo J. D., Gill H., Subramaniapillai M., et al. (2023). COVID-19 vaccination for the prevention and treatment of long COVID: a systematic review and meta-analysis. Brain Behav. Immun. 111, 211&#x2013;229. 10.1016/j.bbi.2023.03.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2023.03.022</ArticleId><ArticleId IdType="pmc">PMC10067136</ArticleId><ArticleId IdType="pubmed">36990297</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F., Leber A., Jawad M. Y., Yu M., Lui L. M. W., Subramaniapillai M., et al. (2022). Registered clinical trials investigating treatment of long COVID: a scoping review and recommendations for research. Infect. Dis. Lond. 54 (7), 467&#x2013;477. 10.1080/23744235.2022.2043560</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2022.2043560</ArticleId><ArticleId IdType="pmc">PMC8935463</ArticleId><ArticleId IdType="pubmed">35282780</ArticleId></ArticleIdList></Reference><Reference><Citation>Damoiseaux J., Andrade L. E., Fritzler M. J., Shoenfeld Y. (2015). Autoantibodies 2015: from diagnostic biomarkers toward prediction, prognosis and prevention. Autoimmun. Rev. 14 (6), 555&#x2013;563. 10.1016/j.autrev.2015.01.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2015.01.017</ArticleId><ArticleId IdType="pubmed">25661979</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H. E., McCorkell L., Vogel J. M., Topol E. J. (2023). Long COVID: major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 21 (3), 133&#x2013;146. 10.1038/s41579-022-00846-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>DiMeglio L. A., Evans-Molina C., Oram RAJTL. (2018). Type 1 diabetes. Lancet 391 (10138), 2449&#x2013;2462. 10.1016/S0140-6736(18)31320-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(18)31320-5</ArticleId><ArticleId IdType="pmc">PMC6661119</ArticleId><ArticleId IdType="pubmed">29916386</ArticleId></ArticleIdList></Reference><Reference><Citation>Efron B. (2011). Tweedie's Formula and selection bias. J. Am. Stat. Assoc. 106 (496), 1602&#x2013;1614. 10.1198/jasa.2011.tm11181</Citation><ArticleIdList><ArticleId IdType="doi">10.1198/jasa.2011.tm11181</ArticleId><ArticleId IdType="pmc">PMC3325056</ArticleId><ArticleId IdType="pubmed">22505788</ArticleId></ArticleIdList></Reference><Reference><Citation>Filippi M., Bar-Or A., Piehl F., Preziosa P., Solari A., Vukusic S., et al. (2018). Multiple sclerosis. Nat. Rev. Dis. Prim. 4 (1), 43. 10.1038/s41572-018-0041-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41572-018-0041-4</ArticleId><ArticleId IdType="pubmed">30410033</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiocchi C. (1998). Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115 (1), 182&#x2013;205. 10.1016/s0016-5085(98)70381-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0016-5085(98)70381-6</ArticleId><ArticleId IdType="pubmed">9649475</ArticleId></ArticleIdList></Reference><Reference><Citation>Forcione D. G., Rosen M. J., Kisiel J. B., Sands B. E. (2004). Anti-Saccharomyces cerevisiae antibody (ASCA) positivity is associated with increased risk for early surgery in Crohn's disease. Gut 53 (8), 1117&#x2013;1122. 10.1136/gut.2003.030734</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gut.2003.030734</ArticleId><ArticleId IdType="pmc">PMC1774147</ArticleId><ArticleId IdType="pubmed">15247177</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg M., Royce S. G., Tikellis C., Shallue C., Batu D., Velkoska E., et al. (2020). Imbalance of the renin-angiotensin system may contribute to inflammation and fibrosis in IBD: a novel therapeutic target? Gut 69 (5), 841&#x2013;851. 10.1136/gutjnl-2019-318512</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2019-318512</ArticleId><ArticleId IdType="pubmed">31409604</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D., Sun A., Ssentongo A. E., Ba D. M., Parsons N., Poudel G. R., et al. (2021). Short-term and long-term rates of Postacute sequelae of SARS-CoV-2 infection: a systematic review. JAMA Netw. Open 4 (10), e2128568. 10.1001/jamanetworkopen.2021.28568</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.28568</ArticleId><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Y., Li D., Hu Y. (2023). Appraising the associations between systemic Iron Status and Epigenetic Clocks: a genetic correlation and bidirectional Mendelian randomization study. Am. J. Clin. Nutr. 118 (1), 41&#x2013;49. 10.1016/j.ajcnut.2023.05.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajcnut.2023.05.004</ArticleId><ArticleId IdType="pubmed">37146762</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemani G., Zheng J., Elsworth B., Wade K. H., Haberland V., Baird D., et al. (2018). The MR-Base platform supports systematic causal inference across the human phenome. Elife 7, e34408. 10.7554/eLife.34408</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.34408</ArticleId><ArticleId IdType="pmc">PMC5976434</ArticleId><ArticleId IdType="pubmed">29846171</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M., Kleine-Weber H., Schroeder S., Kruger N., Herrler T., Erichsen S., et al. (2020). SARS-CoV-2 cell Entry Depends on ACE2 and TMPRSS2 and is Blocked by a clinically proven Protease Inhibitor. Cell 181 (2), 271&#x2013;280. 10.1016/j.cell.2020.02.052</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs E. T., Catalfamo C. J., Colombo P. M., Khan S. M., Austhof E., Cordova-Marks F., et al. (2023). Pre-existing conditions associated with post-acute sequelae of COVID-19. J. Autoimmun. 135, 102991. 10.1016/j.jaut.2022.102991</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2022.102991</ArticleId><ArticleId IdType="pmc">PMC9816074</ArticleId><ArticleId IdType="pubmed">36634460</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy O. J., Pirastu N., Poole R., Fallowfield J. A., Hayes P. C., Grzeszkowiak E. J., et al. (2020). Coffee Consumption and Kidney function: a Mendelian randomization study. Am. J. Kidney Dis. 75 (5), 753&#x2013;761. 10.1053/j.ajkd.2019.08.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2019.08.025</ArticleId><ArticleId IdType="pubmed">31837886</ArticleId></ArticleIdList></Reference><Reference><Citation>Klebl F. H., Bataille F., Bertea C. R., Herfarth H., Hofstadter F., Scholmerich J., et al. (2003). Association of perinuclear antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibodies with Vienna classification subtypes of Crohn's disease. Inflamm. Bowel Dis. 9 (5), 302&#x2013;307. 10.1097/00054725-200309000-00003</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00054725-200309000-00003</ArticleId><ArticleId IdType="pubmed">14555913</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight J. S., Caricchio R., Casanova J. L., Combes A. J., Diamond B., Fox S. E., et al. (2021). The intersection of COVID-19 and autoimmunity. J. Clin. Invest 131 (24), e154886. 10.1172/JCI154886</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI154886</ArticleId><ArticleId IdType="pmc">PMC8670833</ArticleId><ArticleId IdType="pubmed">34710063</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurki M. I., Karjalainen J., Palta P., Sipil&#xe4; T. P., Kristiansson K., Donner K. M., et al. (2023). FinnGen provides genetic insights from a well-phenotyped isolated population. Nature 613 (7944), 508&#x2013;518. 10.1038/s41586-022-05473-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05473-8</ArticleId><ArticleId IdType="pmc">PMC9849126</ArticleId><ArticleId IdType="pubmed">36653562</ArticleId></ArticleIdList></Reference><Reference><Citation>Lammi V., Nakanishi T., Jones S. E., Andrews S. J., Karjalainen J., Cort&#xe9;s B., et al. Genome-wide association study of long COVID. 2023:2023. medRxiv06.29.23292056.</Citation></Reference><Reference><Citation>Lechner-Scott J., Levy M., Hawkes C., Yeh A., Giovannoni G. (2021). Long COVID or post COVID-19 syndrome. Mult. Scler. Relat. Disord. 55, 103268. 10.1016/j.msard.2021.103268</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.msard.2021.103268</ArticleId><ArticleId IdType="pmc">PMC8447548</ArticleId><ArticleId IdType="pubmed">34601388</ArticleId></ArticleIdList></Reference><Reference><Citation>Ledford H. (2023). Gene linked to long COVID found in analysis of thousands of patients. Nature 619 (7970), 445. 10.1038/d41586-023-02269-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-023-02269-2</ArticleId><ArticleId IdType="pubmed">37433943</ArticleId></ArticleIdList></Reference><Reference><Citation>Lerner A., Jeremias P., Matthias T. (2015). The World incidence and Prevalence of autoimmune diseases is increasing. Int. J. Celiac Dis. 3 (4), 151&#x2013;155. 10.12691/ijcd-3-4-8</Citation><ArticleIdList><ArticleId IdType="doi">10.12691/ijcd-3-4-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Sawalha A. H., Lu Q. (2021). COVID-19 and autoimmune diseases. Curr. Opin. Rheumatology 33 (2), 155&#x2013;162. 10.1097/bor.0000000000000776</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/bor.0000000000000776</ArticleId><ArticleId IdType="pmc">PMC7880581</ArticleId><ArticleId IdType="pubmed">33332890</ArticleId></ArticleIdList></Reference><Reference><Citation>Marrack P., Kappler J., Kotzin B. L. (2001). Autoimmune disease: why and where it occurs. Nat. Med. 7 (8), 899&#x2013;905. 10.1038/90935</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/90935</ArticleId><ArticleId IdType="pubmed">11479621</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehandru S., Merad M. (2022). Pathological sequelae of long-haul COVID. Nat. Immunol. 23 (2), 194&#x2013;202. 10.1038/s41590-021-01104-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01104-y</ArticleId><ArticleId IdType="pmc">PMC9127978</ArticleId><ArticleId IdType="pubmed">35105985</ArticleId></ArticleIdList></Reference><Reference><Citation>Moschen A. R., Tilg H., Raine T. (2019). IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targeting. Nat. Rev. Gastroenterol. Hepatol. 16 (3), 185&#x2013;196. 10.1038/s41575-018-0084-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41575-018-0084-8</ArticleId><ArticleId IdType="pubmed">30478416</ArticleId></ArticleIdList></Reference><Reference><Citation>Pablos J. L., Galindo M., Carmona L., Lledo A., Retuerto M., Blanco R., et al. (2020). Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study. Ann. Rheum. Dis. 79 (12), 1544&#x2013;1549. 10.1136/annrheumdis-2020-218296</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-218296</ArticleId><ArticleId IdType="pubmed">32796045</ArticleId></ArticleIdList></Reference><Reference><Citation>Panda S., Ding J. L. (2015). Natural antibodies bridge innate and adaptive immunity. J. Immunol. 194 (1), 13&#x2013;20. 10.4049/jimmunol.1400844</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1400844</ArticleId><ArticleId IdType="pubmed">25527792</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierce B. L., VanderWeele T. J. (2012). The effect of non-differential measurement error on bias, precision and power in Mendelian randomization studies. Int. J. Epidemiol. 41 (5), 1383&#x2013;1393. 10.1093/ije/dys141</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dys141</ArticleId><ArticleId IdType="pubmed">23045203</ArticleId></ArticleIdList></Reference><Reference><Citation>Puel A., Bastard P., Bustamante J., Casanova J. L. (2022). Human autoantibodies underlying infectious diseases. J. Exp. Med. 219 (4), e20211387. 10.1084/jem.20211387</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20211387</ArticleId><ArticleId IdType="pmc">PMC8952682</ArticleId><ArticleId IdType="pubmed">35319722</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman A., Isenberg D. A. (2008). Systemic lupus Erythematosus. N. Engl. J. Med. 358 (9), 929&#x2013;939. 10.1056/NEJMra071297</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra071297</ArticleId><ArticleId IdType="pubmed">18305268</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramakrishnan R. K., Kashour T., Hamid Q., Halwani R., Tleyjeh I. M. (2021). Unraveling the Mystery Surrounding post-acute sequelae of COVID-19. Front. Immunol. 12, 686029. 10.3389/fimmu.2021.686029</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.686029</ArticleId><ArticleId IdType="pmc">PMC8278217</ArticleId><ArticleId IdType="pubmed">34276671</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B., Bluemke D. A., Luscher T. F., Neubauer S. (2022). Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus. Eur. Heart J. 43 (11), 1157&#x2013;1172. 10.1093/eurheartj/ehac031</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac031</ArticleId><ArticleId IdType="pmc">PMC8903393</ArticleId><ArticleId IdType="pubmed">35176758</ArticleId></ArticleIdList></Reference><Reference><Citation>Sacchi M. C., Tamiazzo S., Stobbione P., Agatea L., De Gaspari P., Stecca A., et al. (2021). SARS-CoV-2 infection as a trigger of autoimmune response. Clin. Transl. Sci. 14 (3), 898&#x2013;907. 10.1111/cts.12953</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cts.12953</ArticleId><ArticleId IdType="pmc">PMC8212749</ArticleId><ArticleId IdType="pubmed">33306235</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawalha A. H., Zhao M., Coit P., Lu Q. (2020). Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients. Clin. Immunol. 215, 2020.03.30.20047852. 10.1101/2020.03.30.20047852</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.03.30.20047852</ArticleId><ArticleId IdType="pmc">PMC7139239</ArticleId><ArticleId IdType="pubmed">32276140</ArticleId></ArticleIdList></Reference><Reference><Citation>Sekula P., Del Greco M. F., Pattaro C., Kottgen A. (2016). Mendelian randomization as an approach to assess causality using observational data. J. Am. Soc. Nephrol. 27 (11), 3253&#x2013;3265. 10.1681/ASN.2016010098</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2016010098</ArticleId><ArticleId IdType="pmc">PMC5084898</ArticleId><ArticleId IdType="pubmed">27486138</ArticleId></ArticleIdList></Reference><Reference><Citation>Senthamizhselvan K., Ramalingam R., Mohan P., Kavadichanda C., Badhe B., Hamide A. (2021). De novo Crohn's disease triggered after COVID-19: is COVID-19 more Tha n an infectious disease? ACG Case Rep. J. 8 (8), e00652. 10.14309/crj.0000000000000652</Citation><ArticleIdList><ArticleId IdType="doi">10.14309/crj.0000000000000652</ArticleId><ArticleId IdType="pmc">PMC8386903</ArticleId><ArticleId IdType="pubmed">34476279</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen W., Song Z., Zhong X., Huang M., Shen D., Gao P., et al. (2022). Sangerbox: a comprehensive, interaction-friendly clinical bioinformatics analysis platform. iMeta 1 (3), e36. 10.1002/imt2.36</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/imt2.36</ArticleId><ArticleId IdType="pmc">PMC10989974</ArticleId><ArticleId IdType="pubmed">38868713</ArticleId></ArticleIdList></Reference><Reference><Citation>Simmons D. P., Nguyen H. N., Gomez-Rivas E., Jeong Y., Jonsson A. H., Chen A. F., et al. (2022). SLAMF7 engagement superactivates macrophages in acute and chronic inflammation. Sci. Immunol. 7 (68), eabf2846. 10.1126/sciimmunol.abf2846</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abf2846</ArticleId><ArticleId IdType="pmc">PMC8991457</ArticleId><ArticleId IdType="pubmed">35148199</ArticleId></ArticleIdList></Reference><Reference><Citation>Sin D. D. (2023). Is long COVID an autoimmune disease? Eur. Respir. J. 61 (1), 2202272. 10.1183/13993003.02272-2022</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.02272-2022</ArticleId><ArticleId IdType="pubmed">36634924</ArticleId></ArticleIdList></Reference><Reference><Citation>Smolen J. S., Aletaha D., Barton A., Burmester G. R., Emery P., Firestein G. S., et al. (2018). Rheumatoid arthritis. Nat. Rev. Dis. Prim. 4 (1), 18001. 10.1038/nrdp.2018.1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2018.1</ArticleId><ArticleId IdType="pubmed">29417936</ArticleId></ArticleIdList></Reference><Reference><Citation>Song L., Zhou R., Huang S., Zhou F., Xu S., Wang W., et al. (2013). High intestinal and systemic levels of interleukin-23/T-helper 17 pathway in Chinese patients with inflammatory bowel disease. Mediat. Inflamm. 2013, 425915. 10.1155/2013/425915</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/425915</ArticleId><ArticleId IdType="pmc">PMC3870108</ArticleId><ArticleId IdType="pubmed">24382939</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y., Yuan D., Chen D. G., Ng R. H., Wang K., Choi J., et al. (2022). Multiple early factors anticipate post-acute COVID-19 sequelae. Cell 185 (5), 881&#x2013;895.e20. 10.1016/j.cell.2022.01.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugihara T., Kobori A., Imaeda H., Tsujikawa T., Amagase K., Takeuchi K., et al. (2010). The increased mucosal mRNA expressions of complement C3 and interleukin-17 in inflammatory bowel disease. Clin. Exp. Immunol. 160 (3), 386&#x2013;393. 10.1111/j.1365-2249.2010.04093.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2249.2010.04093.x</ArticleId><ArticleId IdType="pmc">PMC2883109</ArticleId><ArticleId IdType="pubmed">20089077</ArticleId></ArticleIdList></Reference><Reference><Citation>Taeschler P., Cervia C., Zurbuchen Y., Hasler S., Pou C., Tan Z., et al. (2022). Autoantibodies in COVID-19 correlate with antiviral humoral responses and distinct immune signatures. Allergy 77 (8), 2415&#x2013;2430. 10.1111/all.15302</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.15302</ArticleId><ArticleId IdType="pmc">PMC9111424</ArticleId><ArticleId IdType="pubmed">35364615</ArticleId></ArticleIdList></Reference><Reference><Citation>Taghadosi M., Safarzadeh E., Asgarzadeh A., Roghani S. A., Shamsi A., Jalili C., et al. (2023). Partners in crime: autoantibodies complicit in COVID-19 pathogenesis. Rev. Med. Virol. 33 (2), e2412. 10.1002/rmv.2412</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2412</ArticleId><ArticleId IdType="pmc">PMC9877745</ArticleId><ArticleId IdType="pubmed">36471421</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao S. S., Wang X. Y., Yang X. K., Liu Y. C., Fu Z. Y., Zhang L. Z., et al. (2022). COVID-19 and inflammatory bowel disease crosstalk: from emerging association to clinical proposal. J. Med. Virol. 94 (12), 5640&#x2013;5652. 10.1002/jmv.28067</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28067</ArticleId><ArticleId IdType="pmc">PMC9538900</ArticleId><ArticleId IdType="pubmed">35971954</ArticleId></ArticleIdList></Reference><Reference><Citation>Trier N. H., Houen G. (2023). Antibody cross-reactivity in Auto-immune diseases. Int. J. Mol. Sci. 24 (17), 13609. 10.3390/ijms241713609</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms241713609</ArticleId><ArticleId IdType="pmc">PMC10487534</ArticleId><ArticleId IdType="pubmed">37686415</ArticleId></ArticleIdList></Reference><Reference><Citation>Tursi A., Nenna R. (2022). COVID-19 as a trigger for de novo Crohn's disease. Inflamm. bowel Dis. 28 (6), e76&#x2013;e77. 10.1093/ibd/izab298</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ibd/izab298</ArticleId><ArticleId IdType="pmc">PMC8690164</ArticleId><ArticleId IdType="pubmed">35657373</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaucher J., Keating B. J., Lasserre A. M., Gan W., Lyall D. M., Ward J., et al. (2018). Cannabis use and risk of schizophrenia: a Mendelian randomization study. Mol. Psychiatry 23 (5), 1287&#x2013;1292. 10.1038/mp.2016.252</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mp.2016.252</ArticleId><ArticleId IdType="pmc">PMC5984096</ArticleId><ArticleId IdType="pubmed">28115737</ArticleId></ArticleIdList></Reference><Reference><Citation>Verbanck M., Chen C. Y., Neale B., Do R. (2018). Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat. Genet. 50 (5), 693&#x2013;698. 10.1038/s41588-018-0099-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-018-0099-7</ArticleId><ArticleId IdType="pmc">PMC6083837</ArticleId><ArticleId IdType="pubmed">29686387</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q., Shi Q., Lu J., Wang Z., Hou J. (2022). Causal relationships between inflammatory factors and multiple myeloma: a bidirectional Mendelian randomization study. Int. J. Cancer 151 (10), 1750&#x2013;1759. 10.1002/ijc.34214</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ijc.34214</ArticleId><ArticleId IdType="pubmed">35841389</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei Y., Lu X., Liu C. (2023). Gut microbiota and chronic obstructive pulmonary disease: a Mendelian randomization study. Front. Microbiol. 14, 1196751. 10.3389/fmicb.2023.1196751</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2023.1196751</ArticleId><ArticleId IdType="pmc">PMC10315658</ArticleId><ArticleId IdType="pubmed">37405157</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia C., Dissanayake J., Badov D. (2023). A new Onset of ulcerative colitis post-COVID-19: a case report. Cureus 15 (3), e36257. 10.7759/cureus.36257</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.36257</ArticleId><ArticleId IdType="pmc">PMC10105639</ArticleId><ArticleId IdType="pubmed">37069864</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie J., Huang H., Liu Z., Li Y., Yu C., Xu L., et al. (2023). The associations between modifiable risk factors and nonalcoholic fatty liver disease: a comprehensive Mendelian randomization study. Hepatology 77 (3), 949&#x2013;964. 10.1002/hep.32728</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.32728</ArticleId><ArticleId IdType="pubmed">35971878</ArticleId></ArticleIdList></Reference><Reference><Citation>Ze X. X., Joseph S. M., Song Guo Z. (2021). An updated advance of autoantibodies in autoimmune diseases. Autoimmun. Rev. 20 (2), 102743. 10.1016/j.autrev.2020.102743</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2020.102743</ArticleId><ArticleId IdType="pubmed">33333232</ArticleId></ArticleIdList></Reference><Reference><Citation>Zen M., Fuzzi E., Astorri D., Saccon F., Padoan R., Ienna L., et al. (2020). SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: a cross-sectional study on 916 patients. J. Autoimmun. 112, 102502. 10.1016/j.jaut.2020.102502</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2020.102502</ArticleId><ArticleId IdType="pmc">PMC7832807</ArticleId><ArticleId IdType="pubmed">32527675</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y. Z., Li Y. Y. (2014). Inflammatory bowel disease: pathogenesis. World J. Gastroenterol. 20 (1), 91&#x2013;99. 10.3748/wjg.v20.i1.91</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v20.i1.91</ArticleId><ArticleId IdType="pmc">PMC3886036</ArticleId><ArticleId IdType="pubmed">24415861</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong J., Shen G., Yang H., Huang A., Chen X., Dong L., et al. (2020). COVID-19 in patients with rheumatic disease in Hubei province, China: a multicentre retrospective observational study. Lancet Rheumatol. 2 (9), e557&#x2013;e564. 10.1016/S2665-9913(20)30227-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2665-9913(20)30227-7</ArticleId><ArticleId IdType="pmc">PMC7333992</ArticleId><ArticleId IdType="pubmed">32838309</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuber V., Colijn J. M., Klaver C., Burgess S. (2020). Selecting likely causal risk factors from high-throughput experiments using multivariable Mendelian randomization. Nat. Commun. 11 (1), 29. 10.1038/s41467-019-13870-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-13870-3</ArticleId><ArticleId IdType="pmc">PMC6946691</ArticleId><ArticleId IdType="pubmed">31911605</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>